Researchers develop AI-driven tool for near real-time cancer surveillance

by Mark Alewine,Oak Ridge National LaboratoryCancer cell during cell division. Credit: National Institutes of HealthArtificial intelligence has delivered a major win for pathologists and researc

Updated on: March 20,2024 12

Researchers develop AI-driven tool for near real-time cancer surveillance

by Mark Alewine,Oak Ridge National LaboratoryCancer cell during cell division. Credit: National Institutes of HealthArtificial intelligence has delivered a major win for pathologists and researc

Updated on:March 20,2024 12

Expert panel highlights patient choice for prostate cancer screen (Update)

by Dennis Thompson, Healthday ReporterMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0(HealthDay)—More men could receiv

Updated on: April 01,2024 18

Expert panel highlights patient choice for prostate cancer screen (Update)

by Dennis Thompson, Healthday ReporterMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0(HealthDay)—More men could receiv

Updated on:April 01,2024 18

Cancer mortality higher among American Indian and Alaska Native individuals; colorectal cancer before age 50 rising

byAmerican Cancer SocietyResearchers at the American Cancer Society stress improving access to high-quality cancer prevention, early detection, and treatment for this group of individuals. Credi

Updated on: January 02,2024 6

Cancer mortality higher among American Indian and Alaska Native individuals; colorectal cancer before age 50 rising

byAmerican Cancer SocietyResearchers at the American Cancer Society stress improving access to high-quality cancer prevention, early detection, and treatment for this group of individuals. Credi

Updated on:January 02,2024 6

Manipulating mitochondrial shape may limit metastatic cancer, study finds

byUT Southwestern Medical CenterStudy leader Srinivas Malladi, Ph.D., (left) worked with postdoctoral researcher Pravat Kumar Parida, Ph.D., to investigate the changing shape of mitochondria in

Updated on: January 23,2024 10

Manipulating mitochondrial shape may limit metastatic cancer, study finds

byUT Southwestern Medical CenterStudy leader Srinivas Malladi, Ph.D., (left) worked with postdoctoral researcher Pravat Kumar Parida, Ph.D., to investigate the changing shape of mitochondria in

Updated on:January 23,2024 10

Neoantigen DNA vaccine shows promise against aggressive breast cancer in clinical trial

by Julia Evangelou Strait,Washington University School of MedicineA small clinical trial conducted at WashU Medicine shows promising results for patients with triple-negative breast cancer who r

Updated on: December 02,2024 0

Neoantigen DNA vaccine shows promise against aggressive breast cancer in clinical trial

by Julia Evangelou Strait,Washington University School of MedicineA small clinical trial conducted at WashU Medicine shows promising results for patients with triple-negative breast cancer who r

Updated on:December 02,2024 0

Pembrolizumab shows survival benefit for patients with renal cancer

by Elana GotkineFor patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months,

Updated on: May 11,2024 3

Pembrolizumab shows survival benefit for patients with renal cancer

by Elana GotkineFor patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months,

Updated on:May 11,2024 3

Research finds that life-saving intervention is not risk-free in pediatric patients

by Rachel Sauer,CU Anschutz Medical CampusCredit: Unsplash/CC0 Public DomainBlood transfusion is a vital and lifesaving intervention in a broad range of scenarios, from trauma response to cancer

Updated on: January 23,2024 11

Research finds that life-saving intervention is not risk-free in pediatric patients

by Rachel Sauer,CU Anschutz Medical CampusCredit: Unsplash/CC0 Public DomainBlood transfusion is a vital and lifesaving intervention in a broad range of scenarios, from trauma response to cancer

Updated on:January 23,2024 11

As patients live longer, new criteria needed for prostate cancer trials

JANUARY 26, 2024by Olivia Dimmer,Northwestern UniversityKaplan-Meier curves for (A) OS and rPFS and (B) OS and cPFS. cPFS=clinical progression-free survival; OS=overall survival; rPFS=radiograph

Updated on: March 25,2024 7

As patients live longer, new criteria needed for prostate cancer trials

JANUARY 26, 2024by Olivia Dimmer,Northwestern UniversityKaplan-Meier curves for (A) OS and rPFS and (B) OS and cPFS. cPFS=clinical progression-free survival; OS=overall survival; rPFS=radiograph

Updated on:March 25,2024 7

Researchers unlock clues to improving cancer treatment

by Jess Reid,University of Western AustraliaCredit: CC0 Public DomainA research project led by The University of Western Australia in collaboration with Telethon Kids Institute and 13 health res

Updated on: June 22,2024 4

Researchers unlock clues to improving cancer treatment

by Jess Reid,University of Western AustraliaCredit: CC0 Public DomainA research project led by The University of Western Australia in collaboration with Telethon Kids Institute and 13 health res

Updated on:June 22,2024 4

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

Updated on: March 30,2024 19

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

Updated on:March 30,2024 19

New drug combination shows promise for common pediatric brain tumor

by Larry Frum,Johns Hopkins University School of MedicineThe introduction of everolimus with carboplatin treatment induces DNA damage in tumor cells and kills them. Credit: Johns Hopkins Kimmel

Updated on: March 06,2024 19

New drug combination shows promise for common pediatric brain tumor

by Larry Frum,Johns Hopkins University School of MedicineThe introduction of everolimus with carboplatin treatment induces DNA damage in tumor cells and kills them. Credit: Johns Hopkins Kimmel

Updated on:March 06,2024 19

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

by St. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The d

Updated on: March 30,2024 0

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

by St. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The d

Updated on:March 30,2024 0